<i>N</i>-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling
作者:Mei-Jung Lai、Hsueh-Yun Lee、Hsun-Yueh Chuang、Li-Hsun Chang、An-Chi Tsai、Mei-Chuan Chen、Han-Lin Huang、Yi-Wen Wu、Che-Ming Teng、Shiow-Lin Pan、Yi-Min Liu、Samir Mehndiratta、Jing-Ping Liou
DOI:10.1021/acs.jmedchem.5b00659
日期:2015.8.27
series of N-sulfonyl-aminobiaryl derivatives have been examined as novel antitubulin agents. Compound 21 [N-(4′-cyano-3′-fluoro-biphenyl-2-yl)-4-methoxy-benzenesulfonamide] exhibits remarkable antiproliferative activity against four cancer cell lines (pancreatic AsPC-1, lung A549, liver Hep3B, and prostate PC-3) with a mean GI50 value of 57.5 nM. Additional assays reveal that 21 inhibits not only tubulin
一系列N-磺酰基-氨基联芳基衍生物已被检测为新型抗微管蛋白药物。化合物21 [ N -(4'-cyano-3'-fluoro-biphenyl-2-yl)-4-methoxy-benzenesulfonamide] 对四种癌细胞系(胰腺 AsPC-1、肺 A549、肝 Hep3B、和前列腺 PC-3),平均 GI 50值为 57.5 nM。其他测定显示21不仅抑制微管蛋白聚合,而且抑制 STAT3 抑制的磷酸化,IC 50值为 0.2 μM。四种其他化合物(8、10、19和35) 也能够抑制这种磷酸化。这项研究描述了新型N-磺酰基-氨基联芳基(联芳基-苯磺酰胺)作为靶向 STAT3 和微管蛋白的有效抗癌剂。